Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
68
1.580
 Why?
Head and Neck Neoplasms
14
2012
281
1.320
 Why?
Carcinoma, Squamous Cell
12
2011
330
0.890
 Why?
Neck
7
2018
99
0.720
 Why?
Vascular Malformations
3
2010
98
0.670
 Why?
Head
5
2018
70
0.640
 Why?
Patients
1
2018
47
0.590
 Why?
Terminal Care
1
2018
46
0.590
 Why?
Hemangioma
3
2018
84
0.560
 Why?
Laryngectomy
3
2013
27
0.550
 Why?
Attitude to Health
1
2018
191
0.550
 Why?
Flow Cytometry
7
2024
475
0.550
 Why?
Laryngeal Neoplasms
2
2007
42
0.520
 Why?
Carcinoma, Merkel Cell
4
2016
40
0.470
 Why?
Quality of Life
3
2012
843
0.470
 Why?
Laser Therapy
3
2011
84
0.470
 Why?
Laryngeal Diseases
1
2013
12
0.420
 Why?
Herpes Simplex
1
2013
21
0.420
 Why?
Nuclear Proteins
6
2015
242
0.420
 Why?
Parotid Diseases
1
2012
3
0.420
 Why?
Neuromuscular Agents
1
2012
7
0.420
 Why?
Botulinum Toxins, Type A
1
2012
13
0.410
 Why?
Leukoplakia, Oral
1
2011
6
0.390
 Why?
Aminolevulinic Acid
1
2011
8
0.390
 Why?
Lasers, Dye
1
2011
10
0.390
 Why?
Eating
1
2012
158
0.390
 Why?
Photosensitizing Agents
1
2011
19
0.390
 Why?
Photochemotherapy
1
2011
33
0.380
 Why?
Survivors
1
2012
120
0.380
 Why?
Female
30
2024
26829
0.370
 Why?
Humans
49
2024
50201
0.360
 Why?
Middle Aged
21
2024
12356
0.360
 Why?
Male
30
2024
25572
0.350
 Why?
Photoacoustic Techniques
2
2024
71
0.350
 Why?
Cheek
1
2010
9
0.350
 Why?
Lip
1
2010
10
0.340
 Why?
Neoplastic Cells, Circulating
4
2019
74
0.340
 Why?
Facial Neoplasms
1
2010
22
0.340
 Why?
Pain
1
2012
373
0.340
 Why?
Adult
21
2024
13486
0.330
 Why?
Receptors, Progesterone
1
2009
63
0.330
 Why?
Aged
16
2018
9505
0.330
 Why?
Postoperative Complications
3
2012
1027
0.320
 Why?
Lymphatic Vessels
1
2009
53
0.320
 Why?
Skin Neoplasms
4
2016
487
0.310
 Why?
Neoplasms
1
2018
1233
0.300
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1000
0.300
 Why?
Surgical Flaps
1
2009
114
0.300
 Why?
Recurrent Laryngeal Nerve
1
2007
12
0.300
 Why?
Laryngeal Nerves
1
2007
15
0.300
 Why?
Melanoma
2
2022
281
0.290
 Why?
Factor VII
1
2007
3
0.290
 Why?
Erythrocytes
2
2024
83
0.280
 Why?
Intracranial Arteriovenous Malformations
1
2007
30
0.280
 Why?
Dilatation
2
2017
26
0.270
 Why?
Malaria
2
2024
37
0.250
 Why?
Adolescent
11
2024
6459
0.250
 Why?
Gene Silencing
4
2009
114
0.240
 Why?
Disease Models, Animal
3
2016
1419
0.240
 Why?
Cell Proliferation
4
2016
987
0.220
 Why?
Melanoma, Experimental
2
2016
40
0.210
 Why?
Retrospective Studies
10
2015
6190
0.210
 Why?
Treatment Outcome
7
2018
5203
0.210
 Why?
Immunohistochemistry
8
2014
973
0.210
 Why?
Xerostomia
1
2002
2
0.200
 Why?
Muscarinic Agonists
1
2002
11
0.200
 Why?
Sjogren's Syndrome
1
2002
9
0.200
 Why?
Promoter Regions, Genetic
7
2015
466
0.200
 Why?
Endoscopy
2
2015
119
0.200
 Why?
Thiophenes
1
2002
36
0.200
 Why?
Plasmodium yoelii
1
2022
14
0.200
 Why?
Nitric Oxide Synthase Type III
2
2013
78
0.200
 Why?
Quinuclidines
1
2002
40
0.200
 Why?
Transcription Factors
2
2015
563
0.190
 Why?
Veins
3
2010
71
0.190
 Why?
Embolization, Therapeutic
3
2011
88
0.180
 Why?
Azepines
3
2016
19
0.180
 Why?
Triazoles
3
2016
112
0.170
 Why?
Child
10
2012
6862
0.170
 Why?
Child, Preschool
8
2012
3896
0.160
 Why?
Neoplasm Invasiveness
3
2010
269
0.160
 Why?
Mast Cells
1
2018
54
0.150
 Why?
Mice
10
2022
5673
0.150
 Why?
Ki-67 Antigen
3
2013
57
0.150
 Why?
Combined Modality Therapy
4
2018
639
0.150
 Why?
Cricoid Cartilage
1
2017
11
0.150
 Why?
Estradiol
1
2018
215
0.140
 Why?
Trachea
1
2017
52
0.140
 Why?
Mice, Nude
5
2016
252
0.140
 Why?
Follow-Up Studies
3
2011
2188
0.140
 Why?
Biopsy
3
2015
592
0.140
 Why?
Infant
7
2018
3584
0.140
 Why?
Lasers, Semiconductor
2
2022
10
0.140
 Why?
Embolism
1
2016
20
0.130
 Why?
Benzoxazoles
1
2016
11
0.130
 Why?
Neoplasm Staging
2
2010
749
0.130
 Why?
Matrix Metalloproteinase 2
1
2016
58
0.130
 Why?
Qualitative Research
1
2018
337
0.130
 Why?
Matrix Metalloproteinase 9
1
2016
87
0.130
 Why?
Tracheotomy
1
2015
13
0.130
 Why?
TOR Serine-Threonine Kinases
1
2016
77
0.130
 Why?
Tracheal Stenosis
1
2015
12
0.130
 Why?
Laryngostenosis
1
2015
11
0.130
 Why?
Aged, 80 and over
6
2015
3158
0.130
 Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.120
 Why?
Larynx
2
2017
30
0.120
 Why?
Pyrimidines
1
2016
192
0.120
 Why?
Proto-Oncogene Proteins c-myc
1
2014
50
0.120
 Why?
Disease Progression
3
2014
821
0.120
 Why?
Fluorouracil
2
2004
55
0.120
 Why?
Gene Expression Regulation, Neoplastic
3
2015
824
0.110
 Why?
Carcinoma
2
2012
139
0.110
 Why?
DNA Methylation
5
2009
546
0.110
 Why?
Plasmodium falciparum
2
2024
19
0.110
 Why?
Breast Neoplasms
2
2015
1187
0.110
 Why?
Apoptosis
2
2016
1093
0.110
 Why?
Animals
10
2022
13141
0.110
 Why?
Mastication
1
2012
5
0.100
 Why?
Trismus
1
2012
3
0.100
 Why?
DNA, Neoplasm
2
2011
146
0.100
 Why?
Cisplatin
2
2004
275
0.100
 Why?
Adaptor Proteins, Signal Transducing
3
2009
197
0.100
 Why?
Radiotherapy, Adjuvant
1
2012
60
0.100
 Why?
Recurrence
2
2011
660
0.100
 Why?
Receptors, Cell Surface
1
2013
120
0.100
 Why?
Lymphangioma, Cystic
1
2011
10
0.100
 Why?
Cross-Sectional Studies
3
2024
1580
0.100
 Why?
Chemoradiotherapy
1
2012
43
0.100
 Why?
Endothelium, Lymphatic
1
2011
12
0.100
 Why?
Syndrome
1
2012
239
0.100
 Why?
Epigenesis, Genetic
1
2015
371
0.100
 Why?
Antigens, CD
1
2013
216
0.100
 Why?
Administration, Topical
1
2011
57
0.100
 Why?
Propranolol
1
2012
78
0.100
 Why?
Lymphatic Abnormalities
1
2011
22
0.100
 Why?
Immunoenzyme Techniques
4
2016
141
0.100
 Why?
Enteral Nutrition
1
2012
150
0.100
 Why?
Microtubule-Associated Proteins
1
2011
65
0.090
 Why?
Deglutition Disorders
1
2012
75
0.090
 Why?
Homeodomain Proteins
1
2011
86
0.090
 Why?
Brain Neoplasms
1
2014
286
0.090
 Why?
Tumor Suppressor Proteins
1
2011
127
0.090
 Why?
Diagnosis, Differential
2
2011
1041
0.090
 Why?
Risk Assessment
1
2015
1255
0.090
 Why?
Weight Gain
1
2012
234
0.090
 Why?
Epigenomics
1
2011
67
0.090
 Why?
Xenograft Model Antitumor Assays
3
2016
212
0.090
 Why?
Lip Neoplasms
1
2010
3
0.090
 Why?
Neoplasm Proteins
2
2003
321
0.090
 Why?
Diagnostic Imaging
1
2011
179
0.090
 Why?
Neoplastic Stem Cells
1
2011
100
0.090
 Why?
Neoplasm Recurrence, Local
2
2019
630
0.090
 Why?
Survival Rate
3
2011
906
0.080
 Why?
Hospitals, Teaching
1
2010
53
0.080
 Why?
Lasers, Solid-State
1
2010
32
0.080
 Why?
Melanins
1
2009
23
0.080
 Why?
Microsatellite Instability
1
2009
18
0.080
 Why?
Neoadjuvant Therapy
1
2011
119
0.080
 Why?
Medical Records
1
2010
86
0.080
 Why?
Young Adult
3
2024
4052
0.080
 Why?
Mouth
1
2010
31
0.080
 Why?
Vascular Surgical Procedures
1
2011
165
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Carcinoma, Medullary
1
2009
12
0.080
 Why?
Pilot Projects
1
2011
703
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
 Why?
Receptors, Estrogen
1
2009
130
0.080
 Why?
Immunotherapy
1
2011
235
0.080
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.080
 Why?
Muscle, Smooth, Vascular
1
2009
131
0.080
 Why?
Port-Wine Stain
1
2008
14
0.080
 Why?
Blotting, Western
3
2016
587
0.080
 Why?
Dose-Response Relationship, Drug
1
2011
1356
0.080
 Why?
Early Detection of Cancer
2
2022
164
0.070
 Why?
Vascular Endothelial Growth Factor A
1
2008
183
0.070
 Why?
Cytokines
1
2011
607
0.070
 Why?
Thyroid Neoplasms
1
2009
113
0.070
 Why?
Tumor Cells, Cultured
3
2016
462
0.070
 Why?
Factor VIIa
1
2007
9
0.070
 Why?
Practice Guidelines as Topic
1
2010
459
0.070
 Why?
Jaw Diseases
1
2007
6
0.070
 Why?
Infant, Newborn
2
2011
2770
0.070
 Why?
Practice Management, Medical
1
2006
10
0.070
 Why?
Osteonecrosis
1
2007
34
0.070
 Why?
Postoperative Hemorrhage
1
2007
52
0.070
 Why?
Tongue
1
2007
38
0.070
 Why?
Bone Density Conservation Agents
1
2007
74
0.070
 Why?
Cell Line, Tumor
3
2015
1390
0.070
 Why?
Otolaryngology
1
2006
58
0.070
 Why?
Diphosphonates
1
2007
90
0.070
 Why?
Recombinant Proteins
1
2007
480
0.060
 Why?
Prospective Studies
1
2011
2396
0.060
 Why?
Skin
1
2008
416
0.060
 Why?
Mice, Inbred NOD
2
2016
94
0.060
 Why?
Cameroon
1
2024
4
0.060
 Why?
Mice, SCID
2
2016
173
0.060
 Why?
Hemeproteins
1
2024
8
0.060
 Why?
Parasitemia
1
2024
8
0.060
 Why?
Malaria, Falciparum
1
2024
14
0.060
 Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.060
 Why?
Neoplasm Metastasis
2
2015
235
0.060
 Why?
DNA Repair Enzymes
1
2004
42
0.060
 Why?
Ataxia Telangiectasia
1
2004
6
0.060
 Why?
Statistics, Nonparametric
1
2004
193
0.060
 Why?
ROC Curve
1
2024
236
0.060
 Why?
Polymerase Chain Reaction
4
2009
456
0.060
 Why?
Genes, p16
1
2003
9
0.060
 Why?
Radiotherapy
1
2004
124
0.050
 Why?
Lymph Node Excision
1
2004
138
0.050
 Why?
Proteoglycans
1
2003
81
0.050
 Why?
Magnetic Resonance Angiography
2
2018
71
0.050
 Why?
Antigens, Nuclear
2
2013
24
0.050
 Why?
Magnetic Resonance Imaging
2
2007
1529
0.050
 Why?
Transplantation, Heterologous
2
2013
75
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
579
0.050
 Why?
Longitudinal Studies
1
2024
700
0.050
 Why?
Sensitivity and Specificity
1
2024
871
0.050
 Why?
Membrane Glycoproteins
1
2003
244
0.050
 Why?
Double-Blind Method
1
2002
682
0.040
 Why?
Survival Analysis
3
2009
670
0.040
 Why?
Tryptases
1
2018
4
0.040
 Why?
Estrogen Receptor beta
1
2018
54
0.040
 Why?
Arkansas
1
2004
1988
0.040
 Why?
Estrogen Receptor alpha
1
2018
86
0.040
 Why?
Protein Transport
1
2018
183
0.040
 Why?
Ultrasonography, Doppler
1
2018
41
0.040
 Why?
Biopsy, Fine-Needle
2
2009
108
0.040
 Why?
Cadaver
1
2017
96
0.040
 Why?
Pressure
1
2017
105
0.040
 Why?
Serum
1
2016
32
0.030
 Why?
Risk Factors
3
2015
3644
0.030
 Why?
Molecular Imaging
1
2016
54
0.030
 Why?
Drug Synergism
1
2016
152
0.030
 Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
17
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2016
181
0.030
 Why?
Enhancer Elements, Genetic
1
2015
58
0.030
 Why?
Acetylation
1
2015
93
0.030
 Why?
Keratin-20
1
2014
7
0.030
 Why?
Mammography
1
2015
99
0.030
 Why?
G1 Phase Cell Cycle Checkpoints
1
2014
17
0.030
 Why?
Drug Therapy, Combination
1
2016
382
0.030
 Why?
Prognosis
3
2004
1963
0.030
 Why?
Chromatin
1
2015
138
0.030
 Why?
Cell Cycle Proteins
1
2015
166
0.030
 Why?
HEK293 Cells
1
2014
217
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
30
0.030
 Why?
Gene Expression Regulation
1
2018
964
0.030
 Why?
Comorbidity
1
2015
612
0.030
 Why?
Protein Binding
1
2015
655
0.030
 Why?
Down-Regulation
1
2014
342
0.030
 Why?
Actins
1
2013
115
0.030
 Why?
RNA, Messenger
1
2016
1097
0.030
 Why?
Base Sequence
2
2004
653
0.020
 Why?
Lymphocele
1
2011
7
0.020
 Why?
Tissue Survival
1
2011
10
0.020
 Why?
Predictive Value of Tests
1
2014
921
0.020
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
47
0.020
 Why?
Cell Line
1
2014
1010
0.020
 Why?
Tissue Culture Techniques
1
2011
37
0.020
 Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
 Why?
Gluconates
1
2011
1
0.020
 Why?
Gene Expression Profiling
1
2016
1029
0.020
 Why?
Graft Survival
1
2011
153
0.020
 Why?
Indomethacin
1
2011
38
0.020
 Why?
Injections, Subcutaneous
1
2011
51
0.020
 Why?
Interleukin-2
1
2011
70
0.020
 Why?
Carrier Proteins
2
2003
302
0.020
 Why?
Time Factors
2
2007
2909
0.020
 Why?
Interleukin-1beta
1
2011
73
0.020
 Why?
Cyclophosphamide
1
2011
164
0.020
 Why?
Interferon-gamma
1
2011
176
0.020
 Why?
Drug Administration Schedule
1
2011
369
0.020
 Why?
Glottis
1
2010
34
0.020
 Why?
Disease-Free Survival
1
2011
450
0.020
 Why?
Endothelial Cells
1
2011
257
0.020
 Why?
Sclerotherapy
1
2010
46
0.020
 Why?
Calcitonin
1
2009
30
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2011
388
0.020
 Why?
Thyroidectomy
1
2009
59
0.020
 Why?
Paraffin Embedding
1
2008
52
0.020
 Why?
Mice, Transgenic
1
2009
542
0.020
 Why?
Signal Transduction
1
2014
1612
0.020
 Why?
Curettage
1
2007
13
0.020
 Why?
Dental Care
1
2007
11
0.020
 Why?
Mouth Floor
1
2007
5
0.020
 Why?
Polyvinyl Alcohol
1
2007
9
0.020
 Why?
Hyperbaric Oxygenation
1
2007
14
0.020
 Why?
Current Procedural Terminology
1
2006
7
0.020
 Why?
Collateral Circulation
1
2007
39
0.020
 Why?
Pharyngeal Diseases
1
2007
12
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Cutaneous Fistula
1
2007
14
0.020
 Why?
Neck Dissection
1
2007
30
0.020
 Why?
Office Visits
1
2006
41
0.020
 Why?
Angiography
1
2007
128
0.020
 Why?
Fistula
1
2007
26
0.020
 Why?
Salvage Therapy
1
2007
136
0.020
 Why?
Adrenal Cortex Hormones
1
2007
100
0.020
 Why?
Genetic Predisposition to Disease
1
2009
508
0.020
 Why?
Imidazoles
1
2007
128
0.020
 Why?
Preoperative Care
1
2007
167
0.020
 Why?
Ultrasonography
1
2006
438
0.010
 Why?
United States
1
2015
4898
0.010
 Why?
Guanine
1
2004
40
0.010
 Why?
DNA Adducts
1
2004
79
0.010
 Why?
Methylation
1
2004
118
0.010
 Why?
Syndecans
1
2003
34
0.010
 Why?
Syndecan-1
1
2003
72
0.010
 Why?
Base Pair Mismatch
1
2003
22
0.010
 Why?
Cell Count
1
2003
147
0.010
 Why?
Antineoplastic Agents
1
2011
1176
0.010
 Why?
DNA Repair
1
2003
186
0.010
 Why?
Alcohol Drinking
1
2003
221
0.010
 Why?
Molecular Sequence Data
1
2003
795
0.010
 Why?
Anti-Bacterial Agents
1
2007
744
0.010
 Why?
Smoking
1
2003
506
0.010
 Why?
Multiple Myeloma
1
2007
2934
0.010
 Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (317) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department